<DOC>
	<DOCNO>NCT01053156</DOCNO>
	<brief_summary>This single center study UC Davis MIND Institute patient age 3.5-16 year age fragile X syndrome ( FXS ) , fund National Fragile X Foundation Grant . It control trial minocycline , antibiotic commonly use child infection treatment neurodegenerative disorder . We investigate use FXS lower matrix metalloproteinase 9 ( MMP9 ) level , high FXS , also strengthen brain connection animal model FXS . We hypothesize minocycline likely helpful language , behavior and/or cognition fragile X patient .</brief_summary>
	<brief_title>Trial Minocycline Treat Children With Fragile X Syndrome</brief_title>
	<detailed_description>This single center study UC Davis MIND Institute patient age 3.5-16 year age fragile X syndrome ( FXS ) , fund National Fragile X Foundation Grant . It control trial minocycline , antibiotic commonly use child infection treatment neurodegenerative disorder . We investigate use FXS lower matrix metalloproteinase 9 ( MMP9 ) level , high FXS , also strengthen brain connection animal model FXS . We hypothesize minocycline likely helpful language , behavior and/or cognition fragile X patient . The aim study carry double-blind placebo control trial minocycline treatment child FXS 3.5 16 year age . At baseline , assess behavior perceptual cognitive development . After child treat 3 month either minocycline placebo , undergo baseline test . They cross treated second 3 month . We carry test end second 3 month period . We also assess side effect minocycline treatment throughout study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fragile X Syndrome</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Must fragile X syndrome molecular documentation Current pharmacological treatment regimen stable least 4 week Subjects plan initiate change pharmacologic nonpharmacologic intervention course study subject unable take oral medication subject minocycline previously subject allergic minocycline tetracycline subject pregnant subject history lupus hepatic dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>42 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Fragile X syndrome</keyword>
	<keyword>minocycline</keyword>
	<keyword>target treatment</keyword>
</DOC>